Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPujol Rojo, Miquel-
dc.contributor.authorLimón, Enrique-
dc.contributor.authorSopena, Nieves-
dc.contributor.authorLópez-Contreras, Joaquín-
dc.contributor.authorCastellà, Laia-
dc.contributor.authorCuquet, Jordi-
dc.contributor.authorLópez-Sánchez, Maria-
dc.contributor.authorPérez, Rafel-
dc.contributor.authorGudiol González, Carlota-
dc.contributor.authorColoma, Ana-
dc.contributor.authorMarimón, Mariló-
dc.contributor.authorEspinach, Joan-
dc.contributor.authorAndres, Marta-
dc.contributor.authorMartos, Purificación-
dc.contributor.authorHernández, Sergi-
dc.contributor.authorAlmendral, Alexander-
dc.contributor.authorSaliba, Patrick-
dc.contributor.authorCarvalho Rodrigues, Gonçalo-
dc.contributor.authorCalbo, Esther-
dc.description.abstractBackground: The 2016 cumulative incidence of Clostridioides difficile infection (CDI) in Spain was reported by the European Center for Disease Control to be above the mean of other European countries. The aim of this multicenter prospective observational cohort study was to examine the risk factors that determine 90-day CDI recurrence in Catalonia, Spain. Methods: The study included 558 consecutive adults admitted to hospital who had a symptomatic, first positive CDI diagnosis. Sociodemographic, clinical and epidemiological variables were recorded. The primary outcome was 90-day CDI recurrence. Results: In this Catalan population, having received more than one course of antibiotics in the 30 days prior to CDI diagnosis (odds ratio: 2.459; 95% CI: 1.195-5.060; p = 0.015) and active chemotherapy (odds ratio: 4.859; 95% CI: 1.495-15.792; p = 0.009) are significant predictors of 90-day CDI recurrence. Conclusion: The identification of independent risk factors of 90-day CDI recurrence will enable the optimization of preventive measures in at-risk populations.-
dc.format.extent9 p.-
dc.publisherFuture Medicine-
dc.relation.isformatofVersió postprint del document publicat a:
dc.relation.ispartofFuture Microbiology, 2022, num. 17, p. 1445-1453-
dc.rights(c) Future Medicine, 2022-
dc.sourceArticles publicats en revistes (Infermeria de Salut Pública, Salut mental i Maternoinfantil)-
dc.subject.classificationEfectes secundaris dels medicaments-
dc.subject.classificationHigiene hospitalària-
dc.subject.otherDrug side effects-
dc.subject.otherHospital hygiene-
dc.titleClostridioides difficile infection recurrence in the VINCat hospitals: a prospective observational cohort study-
Appears in Collections:Articles publicats en revistes (Infermeria de Salut Pública, Salut mental i Maternoinfantil)
Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
726868.pdf330.99 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.